InnoCare Pharma Ltd 2023 Sustainability Report
Company: InnoCare Pharma Ltd
Sector: Manufacturing
Country: China
Year: 2023
Type: Sustainability Report
Pages: 82
The report presents 2023 as InnoCare's first year in its 2.0 development phase, highlighting expanded access to healthcare through Orelabrutinib's new marginal-zone-lymphoma indication and insurance coverage. It reports 1,113 employees, 24,091.28 MWh of total energy use and 12,134.54 tons of CO2 equivalent GHG emissions. The Group also reports a full year without workplace accidents, with zero work-related fatalities and zero lost-time injuries.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.